Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-013116

Director acquired 8,124 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Troendle August J. Director 2016-02-09 Option exercise +8,124 $0.42 $3,386 29,994 D
Derivatives
Troendle August J. Director 2016-02-09 Option exercise · Stock Option (Right to Buy) −8,124 0 D
Loading xslF345X03/doc4.xml…